aTyr Pharma
LIFE
$1.90
Share price
2.70%
Change (1 day)
-9.95%
Change (1 year)
Categories
aTyr Pharma (LIFE) - P/B ratio
P/B ratio as of June 2024 : 1.56
According to aTyr Pharma's latest financial reports the company has a price-to-book ratio of 1.56.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
aTyr Pharma - P/B ratio (from 2015 to 2024)
P/B ratio by year
| Year | P/B ratio | Change |
|---|---|---|
| 2024-12-31 | N/A | -100% |
| 2023-12-31 | 0.9127 | 2.41% |
| 2022-12-31 | 0.8912 | -53.15% |
| 2021-12-31 | 1.90 | 40.09% |
| 2020-12-31 | 1.36 | 75.94% |
| 2019-12-31 | 0.7718 | 71.34% |
| 2018-12-31 | 0.4505 | -72.21% |
| 2017-12-31 | 1.62 | 99.65% |
| 2016-12-31 | 0.8120 | -59.85% |
| 2015-12-31 | 2.02 | |
| 2014-12-31 | N/A |
P/B ratio for similar companies or competitors
| Company | P/B ratio | differencediff. | Country |
|---|---|---|---|
 Vertex Pharmaceuticals VRTX | 6.59 | 323.76% | 🇺🇸 USA |
 Veracyte VCYT | 1.55 | -0.15% | 🇺🇸 USA |